SLC3A2 and neoplasm: In summary, the novel hCD98hc-specific PASylated Anticalin tracer showed high and specific tumor uptake in two xenograft models with excellent contrast, providing a proof of concept for exploiting CD98hc in non-invasive diagnostic imaging.